Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China flag China · Delayed Price · Currency is CNY
19.05
+0.07 (0.37%)
Sep 14, 2026, 3:04 PM CST

SHE:300357 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
1,0881,058921.46840.75894.88804.12
Other Revenue
4.063.923.947.441.143.58
1,0921,062925.39848.19896.02807.69
Revenue Growth
11.42%14.81%9.10%-5.34%10.94%26.95%
Cost of Revenue
51.0650.5844.8140.1942.5134.44
Gross Profit
1,0411,012880.58808853.5773.25
Selling, General & Admin
498.79479.11434.65385.28359.63333.97
Research & Development
106.18117.1119.88112.2106.0287.93
Other Operating Expenses
12.289.637.844.574.533.78
Operating Expenses
619.06606.46563.23501.05471.43427.23
Operating Income
422.21405.37317.36306.95382.07346.02
Interest Expense
-0.79-0.79-1.06-1.31-0.44-0.36
Interest & Investment Income
50.226.4535.8132.8728.3529.03
Currency Exchange Gain (Loss)
-0-000-0-0
Other Non Operating Income (Expenses)
1.23-0.32-0.34-0.26-0.15-0.17
EBT Excluding Unusual Items
472.84430.7351.76338.25409.82374.52
Gain (Loss) on Sale of Investments
5.413.432.43-0.67-0.88-0.1
Gain (Loss) on Sale of Assets
0.230.630.57--0.27-
Asset Writedown
-5.11-5.11-1.42-0.58-43.23-0.1
Other Unusual Items
0.253.0611.728.9533.318.67
Pretax Income
473.62432.71365.06345.96398.75393
Income Tax Expense
67.3864.6260.7250.4363.0266.71
Earnings From Continuing Operations
406.24368.09304.34295.52335.73326.29
Minority Interest in Earnings
11.1512.8513.4814.6613.0511.7
Net Income
417.38380.94317.82310.18348.77337.99
Net Income to Common
417.38380.94317.82310.18348.77337.99
Net Income Growth
20.77%19.86%2.46%-11.06%3.19%21.38%
Shares Outstanding (Basic)
524524524524524524
Shares Outstanding (Diluted)
524524524524524524
Shares Change
0.00%-0.01%-0.00%--0.00%0.00%
EPS (Basic)
0.800.730.610.590.670.65
EPS (Diluted)
0.800.730.610.590.670.65
EPS Growth
20.77%19.87%2.46%-11.06%3.19%21.38%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
320.77270.9133.12154.61159.62236.33
Free Cash Flow Per Share
0.610.520.250.290.300.45
Dividend Per Share
0.2500.2500.2200.1850.2000.201
Dividend Growth
13.64%13.64%18.92%-7.50%-0.50%25.62%
Gross Margin
95.33%95.24%95.16%95.26%95.25%95.74%
Operating Margin
38.65%38.16%34.29%36.19%42.64%42.84%
Profit Margin
38.21%35.86%34.34%36.57%38.92%41.85%
Free Cash Flow Margin
29.37%25.50%14.39%18.23%17.82%29.26%
EBITDA
476.58455.18360.94338.38402.44366.11
EBITDA Margin
43.63%42.84%39.00%39.89%44.91%45.33%
D&A For EBITDA
54.3649.8143.5931.4320.3720.08
EBIT
422.21405.37317.36306.95382.07346.02
EBIT Margin
38.65%38.16%34.29%36.19%42.64%42.84%
Effective Tax Rate
14.23%14.93%16.63%14.58%15.80%16.97%
Revenue as Reported
1,0921,062925.39848.19896.02807.69